Cytokinetics | CYTK - Market Capitalization


Cytokinetics reported $9.7B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Bayer EUR 38.69B 2.33B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cytokinetics USD 8.19B 420M Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Exelixis USD 10.89B 857M Mar/2026
Geron USD 955M 112M Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026